---
title: "Polylink Polymers (India) Ltd (531454) — Share Price, Financials & Analysis"
symbol: "531454"
company: "Polylink Polymers (India) Ltd"
canonical: "https://tapetide.com/stocks/531454"
isin: "INE323D01020"
nse_symbol: "POLYLINKPOLYMERSLTD"
bse_code: "531454"
sector: "Chemicals"
industry: "Petrochemicals"
market_cap_cr: 51.98
generated_at: "2026-09-13T19:10:08.674Z"
---

# Polylink Polymers (India) Ltd (531454)

Canonical page: https://tapetide.com/stocks/531454

## Company

- **NSE Symbol:** POLYLINKPOLYMERSLTD
- **BSE Code:** 531454
- **ISIN:** INE323D01020
- **Sector:** Chemicals
- **Industry:** Petrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** polylinkpolymers.com

## About

Incorporated in 1993, Polylink Polymers Ltd is engaged in the manufacture and sale of polymeric compounds and color master batches.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:42:15.828040Z.

- **Market Cap:** ₹51.98 Cr
- **Classification:** Microcap
- **P/E (reported):** 35.6
- **EPS (TTM):** ₹0.66
- **EPS (reported):** ₹1.05
- **Book Value:** ₹14.08
- **Price to Book:** 1.67
- **Dividend Yield:** 0%
- **ROE:** 3.93%
- **ROCE:** 5.37%
- **Debt to Equity:** 0.18
- **Revenue (yearly):** ₹85.1 Cr
- **Net Income:** ₹1.2 Cr
- **EBITDA:** ₹3.3 Cr
- **52-Week High:** ₹27
- **52-Week Low:** ₹14.35
- **RSI (14):** 59.16

## Tapetide Score

- **Score:** 49 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Rising
- **Percentile:** 43.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 54.23 | 9% |
| growth | 34.16 | 9% |
| momentum | 82.8 | 12% |
| ownership | 50 | 24% |
| quality | 50.45 | 22% |
| valuation | 33.84 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has a low return on equity of 5.85% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 126.18% | 346.26% | 997.92% |
| ebitda margin growth | -9.09% | -18.49% | -16.74% | -25.67% |
| net income growth | -33.33% | -42.86% | 23% | 1% |
| revenue growth | 7.8% | -6.99% | 19% | 18% |
| roce | — | -49.39% | -37.99% | 6.85% |
| roe | — | -44.88% | 5.76% | 11.65% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 17.43 | 18.86 | 22.39 | 23.73 | 21.05 | 22.42 | 24.04 | 20.66 | 21.88 | 20.45 | 21.61 | 23.45 |
| Expenses | 17 | 18.02 | 21.02 | 22.28 | 20.13 | 20.91 | 23.85 | 20.04 | 21.42 | 19.62 | 20.72 | 22.52 |
| Operating Profit | 0.43 | 0.84 | 1.37 | 1.45 | 0.92 | 1.51 | 0.19 | 0.62 | 0.46 | 0.83 | 0.89 | 0.93 |
| OPM % | 2.47 | 4.45 | 6.12 | 6.11 | 4.37 | 6.74 | 0.79 | 3 | 2.1 | 4.06 | 4.12 | 3.97 |
| Other Income | 0.04 | 0.1 | 0.07 | 0.08 | 0.03 | 0.13 | 0.04 | 0.05 | 0.22 | 0.04 | 0.2 | 0.06 |
| Interest | 0.04 | 0.06 | 0.1 | 0.08 | 0.1 | 0.08 | 0.1 | 0.1 | 0.14 | 0.14 | 0.18 | 0.16 |
| Depreciation | 0.23 | 0.24 | 0.25 | 0.25 | 0.25 | 0.26 | 0.25 | 0.31 | 0.37 | 0.39 | 0.37 | 0.4 |
| Profit before tax | 0.2 | 0.64 | 1.09 | 1.2 | 0.6 | 1.3 | -0.12 | 0.26 | 0.17 | 0.34 | 0.54 | 0.43 |
| Tax % | -5 | 28.12 | 28.44 | 26.67 | 31.67 | 27.69 | -25 | 26.92 | -11.76 | 29.41 | -14.81 | 2.33 |
| Net Profit | 0.21 | 0.45 | 0.79 | 0.88 | 0.41 | 0.95 | -0.1 | 0.19 | 0.18 | 0.24 | 0.61 | 0.42 |
| EPS in Rs | 0.09 | 0.2 | 0.36 | 0.4 | 0.19 | 0.43 | -0.05 | 0.09 | 0.08 | 0.11 | 0.28 | 0.19 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 34.46 | 47.04 | 47.05 | 37.43 | 45.69 | 50.36 | 74.67 | 91.23 | 84.6 | 87.39 |
| Expenses | 31.62 | 44.79 | 45.11 | 35.54 | 43.7 | 48.62 | 71.37 | 87.09 | 81.72 | 84.28 |
| Operating Profit | 2.84 | 2.25 | 1.94 | 1.89 | 1.99 | 1.74 | 3.3 | 4.14 | 2.88 | 3.11 |
| OPM % | 8.24 | 4.78 | 4.12 | 5.05 | 4.36 | 3.46 | 4.42 | 4.54 | 3.4 | 3.56 |
| Other Income | 0.68 | 0.62 | 0.76 | 0.53 | 0.45 | 0.27 | 0.24 | 0.28 | 0.51 | 0.52 |
| Interest | 0.37 | 0.42 | 0.36 | 0.12 | 0.15 | 0.1 | 0.27 | 0.43 | 0.65 | 0.62 |
| Depreciation | 0.9 | 0.87 | 0.9 | 0.82 | 0.89 | 0.94 | 0.95 | 1.01 | 1.45 | 1.53 |
| Profit before tax | 2.25 | 1.58 | 1.44 | 1.48 | 1.4 | 0.97 | 2.32 | 2.98 | 1.29 | 1.48 |
| Tax % | 33.78 | 29.75 | 26.39 | 19.59 | 36.43 | 32.99 | 25 | 28.19 | 5.43 | — |
| Net Profit | 1.49 | 1.11 | 1.07 | 1.19 | 0.9 | 0.64 | 1.73 | 2.13 | 1.22 | 1.45 |
| EPS in Rs | 0.67 | 0.5 | 0.48 | 0.54 | 0.41 | 0.29 | 0.78 | 0.96 | 0.55 | 0.66 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 |
| Reserves | 8.62 | 10.14 | 11.26 | 12.32 | 13.53 | 14.45 | 15.03 | 16.76 | 18.85 | 20.07 |
| Borrowings | 2.58 | 2.62 | 2.98 | 0.42 | 1.38 | 1.87 | 0.45 | 1.9 | 2.58 | 5.75 |
| Other Liabilities | 3.51 | 3.37 | 3.77 | 4.39 | 3.42 | 3.69 | 3.55 | 5.94 | 7.23 | 9.72 |
| Total Liabilities | 25.77 | 27.19 | 29.07 | 28.19 | 29.39 | 31.07 | 30.09 | 35.66 | 39.72 | 46.6 |
| Fixed Assets | 15.49 | 15.86 | 15.9 | 15.75 | 15.25 | 16.33 | 15.79 | 16.2 | 16.38 | 21.6 |
| CWIP | 0 | 0 | 0 | 0 | 1.2 | 0 | 0 | 0 | 0 | 0.09 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 10.28 | 11.33 | 13.17 | 12.44 | 12.94 | 14.74 | 14.3 | 19.46 | 23.34 | 24.91 |
| Total Assets | 25.77 | 27.19 | 29.07 | 28.19 | 29.39 | 31.07 | 30.09 | 35.66 | 39.72 | 46.6 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1.24 | 1.88 | 0.39 | 3.8 | 0.28 | 0.48 | 4.13 | -2.14 | 2.33 | 5.27 |
| Cash from Investing Activity | -0.44 | -1.55 | -0.41 | -0.77 | -1.18 | -0.87 | -0.52 | -0.85 | -2.65 | -7.88 |
| Cash from Financing Activity | -0.96 | -0.33 | -0.03 | -2.94 | 0.71 | 0.36 | -1.49 | 0.87 | 0.33 | 2.61 |
| Net Cash Flow | -0.16 | -0.01 | -0.05 | 0.09 | -0.19 | -0.03 | 2.12 | -2.12 | 0 | 0.01 |
| Free Cash Flow | 0.88 | 0.6 | -0.43 | 3.21 | -1.13 | -0.39 | 3.71 | -3.1 | -0.32 | -2.51 |
| CFO/OP | 72 | 80 | 38 | 213 | 28 | 39 | 245 | -53 | 68 | 189 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 60.32 | 68.32 | 66.03 | 56.4 | 72.84 | 74.21 | 46.97 | 59.05 | 56.09 | 64.76 |
| Inventory Days | 51.14 | 57.68 | 42.34 | 43.73 | 60.72 | 51.2 | 48.21 | 42.83 | 36.9 | 37.05 |
| Days Payable | 42.02 | 34.42 | 24 | 29.71 | 30.63 | 26.29 | 19.9 | 27.19 | 25.69 | 41.87 |
| Cash Conversion Cycle | 69.44 | 91.58 | 84.37 | 70.42 | 102.93 | 99.12 | 75.27 | 74.69 | 67.3 | 59.94 |
| Working Capital Days | 39.8 | 50.84 | 48.88 | 58.57 | 83.57 | 77.89 | 62.4 | 62.62 | 52.85 | 43.4 |
| ROCE % | 11.64 | 11.37 | 8.14 | 7.33 | 6.43 | 5.81 | 4.04 | 9.07 | 10.96 | 5.59 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 74.99% | 74.99% | 74.69% | 74.23% | 72.95% | 72.5% | 72.5% | 72.5% | 72.5% | 72.5% | 72.5% | 72.5% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 23.45% | 22.36% | 23.02% | 23.58% | 24.59% | 24.74% | 24.77% | 24.92% | 24.7% | 24.56% | 24.49% | 24.57% |
| Others | 1.57% | 2.65% | 2.29% | 2.19% | 2.45% | 2.76% | 2.73% | 2.57% | 2.8% | 2.94% | 3.01% | 2.93% |
| No. of Shareholders | 5389 | 5850 | 5913 | 6069 | 6848 | 6964 | 6942 | 6866 | 6817 | 6716 | 6657 | 6833 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 6 / 0

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 22.71 | Buy |
| EMA (10) | 22.86 | Buy |
| SMA (20) | 22.48 | Buy |
| EMA (20) | 22.59 | Buy |
| SMA (50) | 22.05 | Buy |
| EMA (50) | 22.06 | Buy |
| SMA (100) | 21.12 | Buy |
| EMA (100) | 21.44 | Buy |
| SMA (200) | 20.26 | Buy |
| EMA (200) | 21.74 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 57.92 | Neutral |
| MACD (12,26,9) | 0.31 | Buy |
| Stochastic (14,3,3) | 49.3 | Neutral |
| ADX (14) | 32.6 | Buy |
| Williams %R (14) | -51.4 | Neutral |
| ATR (14) | 1.67 | High Volatility |
| ROC (12) | 4.74 | Buy |
| Stoch RSI (14) | 72.42 | Neutral |
| UO (7,14,28) | 47.81 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-21 | [Announcement Under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93be0890-47f5-43e8-a55d-e0b81a1b25f2.pdf) |
| 2026-08-20 | [Intimation Of Book Closure For 33Rd Annual General Meeting For The Financial Year 2025-26.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d74908c-97b0-4935-a1c5-6cecdaf045d7.pdf) |
| 2026-08-20 | [Intimation Of Cut-Off Date For E-Voting For The 33Rd Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fa0f340-4c51-4c15-a7e9-7e69bad4f776.pdf) |
| 2026-08-20 | [Notice Convening The 33Rd Annual General Meeting Of The Company For The Financial Year 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e9b6cc8-0545-4149-9b43-323cad534404.pdf) |
| 2026-08-20 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60b12750-09ce-4a49-8260-9ddc642d0c7f.pdf) |
| 2026-08-20 | [Intimation Under Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8451f9ad-e304-43cd-9465-283e70816013.pdf) |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Cessation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=981eff34-0c6c-4d6b-ba44-723243d377b8.pdf) |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccb7fe26-cbd7-4c3d-a60e-7e3cf2a9a2f2.pdf) |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcd5da89-fe29-474e-8ddc-e482bed0e52e.pdf) |
| 2026-08-10 | [Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulation) Held On 10Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce655e73-428b-46c8-a24e-f1cdd2334193.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-10 | [Quarter Ended June 30 2026 - Unaudited Standalone Financial Results Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0817565-657a-4095-8ab1-3cb3f41e2aad.pdf) |
| 2026-05-29 | [Audited Financial Results For The Quarter And Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c74a93d6-caaa-4bbd-bd7a-abeb42c56518.pdf) |
| 2026-02-06 | [Unaudited Financial Result For The Quarter Ended 31St December2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c00816d2-a1bb-4044-aedd-87ef704c4187.pdf) |
| 2025-11-07 | [The Quarter And Half Year Ended On 30Th September 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1a0fb9b-53a2-4c63-ba5e-b77790cad7d5.pdf) |
| 2025-08-08 | [Unaudited Financial Result For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c67b222-19e6-4a1f-ba52-813fb0810363.pdf) |
| 2025-02-04 | [Financial Results Approval For The Quarter Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5df0f7ad-602c-44d2-a59d-260aceb04c5a.pdf) |
| 2024-10-29 | [Declaration Of Unaudited Financial Results For The Quarter Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1acbd757-f29b-4817-87d5-8a6f51905bfd.pdf) |
| 2024-08-09 | [Results-Unaudited Financial Result For The Quarter End On 30Th June, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=256a2847-1b51-4b58-bb08-957cf442120b.pdf) |
| 2024-05-29 | [Financial Result For 31-03-2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c4b64f0-624a-4d6f-93b3-4b462d4f419e.pdf) |
| 2024-02-05 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th February, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64dbf41a-0bff-4845-8c65-0b2b6392834e.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Jan - Certificate issued under Regulation 74(5) of SEBI (Depositories & Participants) Regulation, 2018. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Jan - Certificate issued under Regulation 74(5) of SEBI (Depositories & Participants) Regulation, 2018.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e4b6dce9-38f0-4db2-b569-d1f5ccb5baa0.pdf) |
| 7 Apr - Regulation 74(5) compliance certificate filed for quarter and year ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Regulation 74(5) compliance certificate filed for quarter and year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f23bf5f6-8b09-4e07-8326-d1cac6c20fe8.pdf) |
| 6 Feb - Board approved unaudited results for quarter/nine months ended 31 Dec 2025; limited review by auditors. | [Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015 ('Listing Regulation') 6 Feb - Board approved unaudited results for quarter/nine months ended 31 Dec 2025; limited review by auditors.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ee1ab55c-d6d2-448a-8af5-650de79e02cd.pdf) |
| 5 January 2026 - Jan 05, 2026 board approved three LLP incorporations; acquire up to 95% of Vinchurkar for Rs.760 lakhs; partial stake sales. | [Sale or disposal 5 January 2026 - Jan 05, 2026 board approved three LLP incorporations; acquire up to 95% of Vinchurkar for Rs.760 lakhs; partial stake sales.](https://nsearchives.nseindia.com/corporate/INVICTA_05012026185558_Intimation_05012026.pdf) |
| 31 Jan - Board meeting Feb 6, 2026 11:00 AM to approve unaudited results for quarter and nine months ended Dec 31, 2025 | [Board Meeting Intimation for Intimation Of The Board Meeting Pursuant To Regulation 29 Read With Regulation 33 Of The SEBI (LODR) Regulation, 2015 31 Jan - Board meeting Feb 6, 2026 11:00 AM to approve unaudited results for quarter and nine months ended Dec 31, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/81bb2685-b3a7-481c-b9be-fdc0eb2039f8.pdf) |
| 30 January 2026 - Primacare started commercial operations at Dadar Centre on 30 Jan 2026; ₹550 lakh investment; PET-CT, CT, pathology services. | [Commencement of commercial production/operations 30 January 2026 - Primacare started commercial operations at Dadar Centre on 30 Jan 2026; ₹550 lakh investment; PET-CT, CT, pathology services.](https://nsearchives.nseindia.com/corporate/INVICTA_30012026201428_Intimation_Dadar_30012026.pdf) |
| 28 January 2026 - Three diagnostic LLPs incorporated (Shegaon 20-Jan-2026; two Mumbai 16-Jan-2026); contributions ₹51,000, ₹99,000, ₹99,000. | [Acquisition 28 January 2026 - Three diagnostic LLPs incorporated (Shegaon 20-Jan-2026; two Mumbai 16-Jan-2026); contributions ₹51,000, ₹99,000, ₹99,000.](https://nsearchives.nseindia.com/corporate/INVICTA_28012026151100_Intimation_28012026_LLPIncorporation.pdf) |
| 28 January 2026 - Invicta incorporated three diagnostic LLPs Jan 16–28, 2026; subscribed cash capital ₹51,000, ₹99,000, ₹99,000. | [Acquisition 28 January 2026 - Invicta incorporated three diagnostic LLPs Jan 16–28, 2026; subscribed cash capital ₹51,000, ₹99,000, ₹99,000.](https://nsearchives.nseindia.com/corporate/INVICTA_28012026151944_Intimation_28012026_LLPIncorporation1.pdf) |
| 27 February 2026 - Completed sale of 9% stake in Primacare Diagnostic LLP for Rs.9,000 on Feb 27, 2026. | [Sale or disposal 27 February 2026 - Completed sale of 9% stake in Primacare Diagnostic LLP for Rs.9,000 on Feb 27, 2026.](https://nsearchives.nseindia.com/corporate/INVICTA_27022026185526_Intimation_Sale_PD.pdf) |
| 27 Dec 2025 - Trading window closed Jan 1, 2026 until 48 hours after unaudited results for quarter ended Dec 31, 2025. | [Closure of Trading Window 27 Dec 2025 - Trading window closed Jan 1, 2026 until 48 hours after unaudited results for quarter ended Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/37ff21c8-96e6-45ba-bd3b-a7eb3ed0ed56.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ed89320-d532-4a08-9597-429a14bba63e.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8fd5bbb8-0749-453b-b4c7-95e64157a769.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7cb29cdd-9683-4a86-9475-049aaf1e7849.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531454/73093531454.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/531454/70915531454.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/531454/65975531454.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/531454/5314540319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/531454/5314540318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/531454/5314540317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/531454/5314540316.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:10:08.674Z.